Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | NDUFS2 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
mRNA | MTIF2 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | SUCLG2 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
mRNA | ATIC | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | PFDN2 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | SUCLG1 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
mRNA | DHODH | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | SPR | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |